As of 2025-01-25, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -222.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,900.72 mil USD. AtriCure's TTM EBITDA according to its financial statements is -8.54 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 17.5x | 17.3x |
| Forward P/E multiples | 18.4x - 28.3x | 21.6x |
| Fair Price | (1.83) - (1.69) | (2.03) |
| Upside | -104.5% - -104.2% | -105.0% |
| Date | EV/EBITDA |
| 2025-01-23 | -221.13 |
| 2025-01-22 | -217.70 |
| 2025-01-21 | -218.45 |
| 2025-01-17 | -211.82 |
| 2025-01-16 | -207.08 |
| 2025-01-15 | -203.25 |
| 2025-01-14 | -190.23 |
| 2025-01-13 | -188.52 |
| 2025-01-10 | -171.50 |
| 2025-01-08 | -184.35 |
| 2025-01-07 | -178.87 |
| 2025-01-06 | -183.38 |
| 2025-01-03 | -175.04 |
| 2025-01-02 | -165.73 |
| 2024-12-31 | -166.65 |
| 2024-12-30 | -164.88 |
| 2024-12-27 | -167.16 |
| 2024-12-26 | -167.73 |
| 2024-12-24 | -166.30 |
| 2024-12-23 | -166.36 |
| 2024-12-20 | -167.56 |
| 2024-12-19 | -163.73 |
| 2024-12-18 | -164.88 |
| 2024-12-17 | -172.01 |
| 2024-12-16 | -172.24 |
| 2024-12-13 | -172.98 |
| 2024-12-12 | -179.38 |
| 2024-12-11 | -182.35 |
| 2024-12-10 | -186.18 |
| 2024-12-09 | -185.95 |
| 2024-12-06 | -187.72 |
| 2024-12-05 | -186.92 |
| 2024-12-04 | -199.48 |
| 2024-12-03 | -198.40 |
| 2024-12-02 | -203.77 |
| 2024-11-29 | -198.63 |
| 2024-11-27 | -198.68 |
| 2024-11-26 | -196.51 |
| 2024-11-25 | -197.77 |
| 2024-11-22 | -196.20 |
| 2024-11-21 | -195.89 |
| 2024-11-20 | -197.89 |
| 2024-11-19 | -199.66 |
| 2024-11-18 | -190.40 |
| 2024-11-15 | -192.17 |
| 2024-11-14 | -193.77 |
| 2024-11-13 | -198.86 |
| 2024-11-12 | -201.31 |
| 2024-11-11 | -210.28 |
| 2024-11-08 | -206.00 |